Market pulse › Pharma and healthcare
Pharma and healthcare
Today19 stories · 30 articles
Net tone● −7% today
Market checkPharma −0.10%
Developing2 storylines
Pharma and healthcare in three lines
- Sun Pharma secured exclusive worldwide rights to Lerodalcibib, excluding the US and China
- Morepen Laboratories submitted its first ANDA to USFDA for Sitagliptin Tablets
- Dr Reddy's shares gained over 1% after Nomura retained its Buy rating
1124 Sept
2125 Sept
726 Sept
527 Sept
1328 Sept
Order win▲ bullishLupin receives USFDA tentative approval for Apixaban Oral Suspension 1.25 mg/mLLupin received USFDA tentative approval for Apixaban Oral Suspension 1.25 mg/mLLupinUSFDA
Broker call▲ bullishDr Reddy's shares gain over 1% after Nomura retains 'Buy'; Rs1,740 target, key biologics milestones aheadDr Reddy'sCDMO
Broker call● mixedShrikant Chouhan recommends buying Torrent Pharma, selling Bharti AirtelBharti Airtel
▲ bullishMorepen Laboratories submits first ANDA to USFDA for Sitagliptin TabletsMorepen Laboratories submitted its first ANDA to USFDA for Sitagliptin TabletsMorepen LaboratoriesUSFDA
Deal● mixedSun Pharma shares in focus after global licensing deal for cholesterol drug; check detailsSun Pharma
Deal▲ bullishSun Pharma signs exclusive licensing agreement with LIB Therapeutics Inc.Sun Pharma secured exclusive rights to commercialize and manufacture Lerodalcibep worldwide, excluding the US and ChinaSun PharmaChina
Market move● mixedDr Reddys Share Price Live Updates: Dr. Reddy's Laboratories shows three-month performance declineDr Reddy's
Market move● mixedApollo Hospital Share Price Live Updates: Apollo Hospital sees a decrease in weekly returnsApollo HospitalsHospitals
Policy● mixedGovt, private hospitals likely to be graded on quality & safetyNiti Aayog is developing a national quality framework for public and private hospitalsHospitals
Policy● mixedCDSCO steps up scrutiny of pharma drugs containing narcotic substancesCDSCO is addressing regulatory gaps around illegal diversion of pharmaceutical drugs containing narcotic substances
● mixedIndian-origin executives in demand to helm C-suite AI strategy globallyHoneywell Aerospace, Boeing, GE Healthcare and others have created chief AI and data officer rolesAIBoeing
Legal● mixedFortis says independent audit will establish non-involvement in Singh brothers’ share transfersSupreme Court cleared the way for an independent forensic audit of the share transfersFortis HealthcareSupreme CourtSingh brothers
Legal● mixedFortis confident of clean chit from audit in Singh brothers’ disputeFortis expects a clean chit from the audit in the Singh brothers’ disputeFortis HealthcareSupreme CourtHospitals
Data● mixedCompanies offering healthcare benefits see 13% drop in chronic claims, says reportCompanies offering healthcare benefits saw a 13% drop in chronic claimsInsuranceHealth insuranceStar Health and Allied Insurance
Expansion● mixedPB Health’s hospital expansion plans on track: PB Fintech Chairman and Group CEOPB FintechHospitalsPaytm
Policy● mixedFood safety vs public health: Maharashtra FDA chief Tukaram Mundhe calls for behaviour changeMaharashtra FDA chief Tukaram Mundhe said food and beverage choices should be considered when assessing illnessMaharashtraFMCG and consumption
Deal▲ bullishDr Lal PathLabs’ arm acquires 80% stake in Ghana’s Sunshine HealthcareDr Lal PathLabs’ arm acquired an 80% stake in Ghana’s Sunshine HealthcareDr Lal PathLabsGhanaHospitals